Natco Pharma starts production at Dehradun unit
Natco Pharma Ltd on Tuesday said it has commenced commercial production at its Dehradun unit.
By PTI |
MUMBAI: Natco Pharma Ltd on Tuesday said it has commenced commercial production at its Dehradun unit.
The company informed the Bombay Stock Exchange that the finished dosage pharmacuetical formulations unit would achieve a capacity level of 300 million tablets per annum and the project is being implemented in stages.
Plans of establishing a parenterals division at Dehradun are also underway, it added.
The share of the company was trading at Rs 102.35, down 4.48 per cent on the BSE.
The company informed the Bombay Stock Exchange that the finished dosage pharmacuetical formulations unit would achieve a capacity level of 300 million tablets per annum and the project is being implemented in stages.
Plans of establishing a parenterals division at Dehradun are also underway, it added.
The share of the company was trading at Rs 102.35, down 4.48 per cent on the BSE.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
